Christiana Care Health Services
Quick facts
Phase 2 pipeline
- Carboplatin, Pemetrexed and Bevacizumab · Oncology
Carboplatin is a platinum-based chemotherapy drug that works by crosslinking DNA, thereby inhibiting cancer cell replication. Pemetrexed is an antifolate drug that inhibits thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase, leading to DNA synthesis inhibition. Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor A (VEGF-A), preventing angiogenesis.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Christiana Care Health Services portfolio CI brief
- Christiana Care Health Services pipeline updates RSS
Related
- Sector hub: All tracked pharma companies